Pub Date : 2024-09-24DOI: 10.1016/j.nmni.2024.101489
Malik Olatunde Oduoye , Samuel Chinonso Ubechu , Marina Ramzy Mourid , Ahmad Ibrahim Ahmad , Abdullahi Adeyemi Adegoke , Umulkhairah Onyioiza Arama , Muhammad Furqan , Saiyad Ali , Bashiru Muhammad Auwal , F.N.U. Fariha , Ankini Mukherjee , Aymar Akilimali
Poliovirus is a deadly disease that needs to be eradicated in the world. Recently, issues with circulating vaccine-derived polioviruses (cVDPVs) in the Democratic Republic of the Congo (DRC) have been raised in the country. This article aims to determine the increase in Type 1 cVDPV1 and Type 2 cVDPV2 in the DRC. Relevant articles on PubMed, Google Scholar, ResearchGate, and Web of Science were searched from 2010 to 2023. Our findings indicate that the Democratic Republic of Congo has struggled with polio outbreaks, with the virus primarily linked to cVDPVs produced from vaccines rather than wild poliovirus. These cVDPVs have the potential to revert to their paralyzing capabilities by evolving from the weakened virus seen in the oral polio vaccination (OPV). Several regions in DRC have reported cVDPV outbreaks of cVDPVs. Numerous cVDPV2 outbreaks were documented in various provinces during the 2017–2018 period. Addressing the cVDPV outbreak in the DRC requires a concerted global effort, involving collaboration among governments, international health organizations, and donor agencies. There should be global support and collaboration among governments, international health organizations, and donor agencies to address the cVDPV outbreak in the DRC.
{"title":"Re-emergence of vaccine-derived polio in the demographic Republic of Congo: Causes and consequences","authors":"Malik Olatunde Oduoye , Samuel Chinonso Ubechu , Marina Ramzy Mourid , Ahmad Ibrahim Ahmad , Abdullahi Adeyemi Adegoke , Umulkhairah Onyioiza Arama , Muhammad Furqan , Saiyad Ali , Bashiru Muhammad Auwal , F.N.U. Fariha , Ankini Mukherjee , Aymar Akilimali","doi":"10.1016/j.nmni.2024.101489","DOIUrl":"10.1016/j.nmni.2024.101489","url":null,"abstract":"<div><div>Poliovirus is a deadly disease that needs to be eradicated in the world. Recently, issues with circulating vaccine-derived polioviruses (cVDPVs) in the Democratic Republic of the Congo (DRC) have been raised in the country. This article aims to determine the increase in Type 1 cVDPV1 and Type 2 cVDPV2 in the DRC. Relevant articles on PubMed, Google Scholar, ResearchGate, and Web of Science were searched from 2010 to 2023. Our findings indicate that the Democratic Republic of Congo has struggled with polio outbreaks, with the virus primarily linked to cVDPVs produced from vaccines rather than wild poliovirus. These cVDPVs have the potential to revert to their paralyzing capabilities by evolving from the weakened virus seen in the oral polio vaccination (OPV). Several regions in DRC have reported cVDPV outbreaks of cVDPVs. Numerous cVDPV2 outbreaks were documented in various provinces during the 2017–2018 period. Addressing the cVDPV outbreak in the DRC requires a concerted global effort, involving collaboration among governments, international health organizations, and donor agencies. There should be global support and collaboration among governments, international health organizations, and donor agencies to address the cVDPV outbreak in the DRC.</div></div>","PeriodicalId":38074,"journal":{"name":"New Microbes and New Infections","volume":"62 ","pages":"Article 101489"},"PeriodicalIF":2.9,"publicationDate":"2024-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142358579","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The recent global resurgence of Mpox (formerly monkeypox), primarily transmitted via close contact and respiratory droplets, highlights a significant shift in its epidemiology, particularly among men who have sex with men (MSM). This resurgence underscores the need for robust public health responses and improved surveillance. This comprehensive review of current literature focuses on recent outbreaks, virology, and available treatments. Epidemiological data were gathered from various international health reports and analysed to understand transmission dynamics and outbreak patterns. Mpox, characterised by symptoms like fever and rash, has shown variable clinical presentations, particularly among immunocompromised individuals. Recent outbreaks have prompted the development of new diagnostic methods and treatments, including antivirals like Tecovirimat and vaccines such as MVA-BN. Studies have demonstrated the effectiveness of these vaccines in preventing infection, which is crucial for outbreak containment. The global response to the Mpox resurgence requires integrated strategies combining vaccination, antiviral treatments, and public health policies tailored to high-risk populations. Future efforts should focus on vaccine distribution equity and enhancing diagnostic capabilities to effectively manage and mitigate the impact of Mpox.
{"title":"The resurgence of monkeypox: Epidemiology, clinical features, and public health implications in the post-smallpox eradication era","authors":"Parminder Singh , Sathvik Belagodu Sridhar , Javedh Shareef , Sirajunisa Talath , Priyanka Mohapatra , Mahalaqua Nazli Khatib , Suhas Ballal , Mandeep Kaur , Deepak Nathiya , Shilpa Sharma , G.V. Siva Prasad , Aashna Sinha , Amit Varma , Ganesh Bushi , Abhay M. Gaidhane , Prakasini Satapathy , Muhammed Shabil , Renu Sah , Jaffar A. Al-Tawfiq , Ranjit Sah , Alfonso J. Rodriguez-Morales","doi":"10.1016/j.nmni.2024.101487","DOIUrl":"10.1016/j.nmni.2024.101487","url":null,"abstract":"<div><div>The recent global resurgence of Mpox (formerly monkeypox), primarily transmitted via close contact and respiratory droplets, highlights a significant shift in its epidemiology, particularly among men who have sex with men (MSM). This resurgence underscores the need for robust public health responses and improved surveillance. This comprehensive review of current literature focuses on recent outbreaks, virology, and available treatments. Epidemiological data were gathered from various international health reports and analysed to understand transmission dynamics and outbreak patterns. Mpox, characterised by symptoms like fever and rash, has shown variable clinical presentations, particularly among immunocompromised individuals. Recent outbreaks have prompted the development of new diagnostic methods and treatments, including antivirals like Tecovirimat and vaccines such as MVA-BN. Studies have demonstrated the effectiveness of these vaccines in preventing infection, which is crucial for outbreak containment. The global response to the Mpox resurgence requires integrated strategies combining vaccination, antiviral treatments, and public health policies tailored to high-risk populations. Future efforts should focus on vaccine distribution equity and enhancing diagnostic capabilities to effectively manage and mitigate the impact of Mpox.</div></div>","PeriodicalId":38074,"journal":{"name":"New Microbes and New Infections","volume":"62 ","pages":"Article 101487"},"PeriodicalIF":2.9,"publicationDate":"2024-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142423146","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-09-24DOI: 10.1016/j.nmni.2024.101488
Dalia Zayed, Salam Momani, Mus'ab Banat, Ala'a B. Al-Tammemi
{"title":"Unveiling the first case of Mpox in Jordan 2024: A Look at the national preparedness and response measures","authors":"Dalia Zayed, Salam Momani, Mus'ab Banat, Ala'a B. Al-Tammemi","doi":"10.1016/j.nmni.2024.101488","DOIUrl":"10.1016/j.nmni.2024.101488","url":null,"abstract":"","PeriodicalId":38074,"journal":{"name":"New Microbes and New Infections","volume":"62 ","pages":"Article 101488"},"PeriodicalIF":2.9,"publicationDate":"2024-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142358580","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-09-24DOI: 10.1016/j.nmni.2024.101490
Hilary Simons, Dipti Patel
{"title":"Polio eradication: A perspective from the UK","authors":"Hilary Simons, Dipti Patel","doi":"10.1016/j.nmni.2024.101490","DOIUrl":"10.1016/j.nmni.2024.101490","url":null,"abstract":"","PeriodicalId":38074,"journal":{"name":"New Microbes and New Infections","volume":"62 ","pages":"Article 101490"},"PeriodicalIF":2.9,"publicationDate":"2024-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142358578","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-09-21DOI: 10.1016/j.nmni.2024.101486
Benson R. Kidenya , Gerald Mboowa , Ivan Sserwadda , Stephen Kanyerezi , Esther Nakafu , Inyasi Lawrence Akaro , Baraka Mkinze , Moses L. Joloba , Jeremiah Seni
Objectives
We investigated the genomic epidemiology of extended-spectrum β-lactamase-producing Enterobacter cloacae (ESBL-Ec) isolates from patients and hospital environment to better understand their distribution to help devising effective strategies for infection prevention and control.
Methods
We screened ESBL-Ec at Bugando Medical Center (BMC) in Mwanza, Tanzania. Rectal swabs from orthopedic patients on admission and swabs from the neighboring inanimate environment were collected. Following microbial culture, DNA was extracted from pure ESBL-Ec, and whole-genome sequencing was done. Sequence typing (ST), plasmid replicons, drug resistance, and virulence genes were deciphered using the Rapid Microbial Analysis Pipeline (rMAP).
Results
We obtained 209 ESBL isolates, of which 15 (7.2 %) were ESBL-Ec [8 (53.3 %) from patients and 7 (46.7 %) from the environment]. Seven isolates were novel and eight were diverse, each with a unique ST. All isolates harbored two to five β-lactamase genes, with the predominance of blaCTX-M-15 (15/15), blaOXA-1 (14/15), blaTEM (14/15) and blaACT (12/15). The most common non β-lactam drug resistance genes were aac(3)-IIa (14/15), aac(6′)-Ib-cr (14/15), fosA (14/15), and qnrB1 (12/15), aph(3″)-Ib (10/15) and aph(6)-Id (10/15). Eleven different types of plasmid replicons were identified in 14/15 of the isolates, harboring one to five plasmids, with the most common plasmids being IncFII (11/15) and IncFIB (10/15). All isolates harbored the outer membrane protein (ompA), and curli protein (csg) was in 14/15 isolates.
Conclusion
Admitted orthopedic patients and the hospital environment act as a reservoir of ESBL-Ec with diverse STs and endowed with drug resistance and arsenals of virulence genes, calling for their routine screening on admission for mitigation of potential subsequent infections.
{"title":"Whole genome-based characterization of extended-spectrum β-lactamase-producing Enterobacter cloacae from orthopedic patients and environment of a tertiary referral hospital in Tanzania","authors":"Benson R. Kidenya , Gerald Mboowa , Ivan Sserwadda , Stephen Kanyerezi , Esther Nakafu , Inyasi Lawrence Akaro , Baraka Mkinze , Moses L. Joloba , Jeremiah Seni","doi":"10.1016/j.nmni.2024.101486","DOIUrl":"10.1016/j.nmni.2024.101486","url":null,"abstract":"<div><h3>Objectives</h3><div>We investigated the genomic epidemiology of extended-spectrum <em>β</em>-lactamase-producing <em>Enterobacter cloacae</em> (ESBL-Ec) isolates from patients and hospital environment to better understand their distribution to help devising effective strategies for infection prevention and control.</div></div><div><h3>Methods</h3><div>We screened ESBL-Ec at Bugando Medical Center (BMC) in Mwanza, Tanzania. Rectal swabs from orthopedic patients on admission and swabs from the neighboring inanimate environment were collected. Following microbial culture, DNA was extracted from pure ESBL-Ec, and whole-genome sequencing was done. Sequence typing (ST), plasmid replicons, drug resistance, and virulence genes were deciphered using the Rapid Microbial Analysis Pipeline (rMAP).</div></div><div><h3>Results</h3><div>We obtained 209 ESBL isolates, of which 15 (7.2 %) were ESBL-Ec [8 (53.3 %) from patients and 7 (46.7 %) from the environment]. Seven isolates were novel and eight were diverse, each with a unique ST. All isolates harbored two to five <em>β</em>-lactamase genes, with the predominance of <em>bla</em><sub><em>CTX-M-15</em></sub> (15/15<em>), bla</em><sub><em>OXA-1</em></sub> (14/15)<em>, bla</em><sub><em>TEM</em></sub> (14/15) and <em>bla</em><sub><em>ACT</em></sub> (12/15). The most common non β-lactam drug resistance genes were <em>aac(3)-IIa</em> (14/15<em>), aac(6′)-Ib-cr</em> (14/15)<em>, fosA</em> (14/15<em>),</em> and <em>qnrB1</em> (12/15<em>), aph(3″)-Ib</em> (10/15) and <em>aph(6)-Id</em> (10/15)<em>.</em> Eleven different types of plasmid replicons were identified in 14/15 of the isolates, harboring one to five plasmids, with the most common plasmids being <em>IncFII</em> (11/15) and <em>IncFIB</em> (10/15). All isolates harbored the outer membrane protein (<em>omp</em>A), and curli protein <em>(csg</em>) was in 14/15 isolates.</div></div><div><h3>Conclusion</h3><div>Admitted orthopedic patients and the hospital environment act as a reservoir of ESBL-Ec with diverse STs and endowed with drug resistance and arsenals of virulence genes, calling for their routine screening on admission for mitigation of potential subsequent infections.</div></div>","PeriodicalId":38074,"journal":{"name":"New Microbes and New Infections","volume":"62 ","pages":"Article 101486"},"PeriodicalIF":2.9,"publicationDate":"2024-09-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2052297524002701/pdfft?md5=69e1e0576ba5035ddcdd853f9e1a34a4&pid=1-s2.0-S2052297524002701-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142311146","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-09-18DOI: 10.1016/j.nmni.2024.101485
Alberto Rizzo
{"title":"Integrating multidisciplinary expertise and technological innovations in tracking infectious diseases","authors":"Alberto Rizzo","doi":"10.1016/j.nmni.2024.101485","DOIUrl":"10.1016/j.nmni.2024.101485","url":null,"abstract":"","PeriodicalId":38074,"journal":{"name":"New Microbes and New Infections","volume":"62 ","pages":"Article 101485"},"PeriodicalIF":2.9,"publicationDate":"2024-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2052297524002695/pdfft?md5=aea3695046fded5511082793efa5c008&pid=1-s2.0-S2052297524002695-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142270767","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-09-12DOI: 10.1016/j.nmni.2024.101484
Satoshi Nishida , Yasuo Ono
Background
Carbapenem-resistant Acinetobacter is of increasing global concern because infections are challenging to treat with standard antibiotics. Here, we identified a previously uncharacterised Acinetobacter sp. clinical isolate as Acinetobacter colistiniresistens co-producing IMP-1 and OXA-58. We also examined expression of genes related to antibiotic susceptibility and drug resistance, including blaIMP.
Methods
The isolate was deposited at the National Institute of Technology and Evaluation (NITE) as Acinetobacter sp. NBRC 110496. Susceptibility was defined according to the Clinical and Laboratory Standards Institute (CLSI) breakpoints. Genomic and clonal analyses were performed to identify species and resistance genes.
Results
The isolate was resistant to β-lactams, including broad-spectrum cephalosporins and carbapenems, polymyxins, and trimethoprim/sulfamethoxazole. Genomic analysis identified the isolate as A. colistiniresistens harbouring blaIMP-1, blaOXA-58, blaOXA-670, aac(6′)-Ib, aac(6′)-Ij, ant(3”)-II, aph(3’)-VI, msrE, mphE, and sul1. Colistin resistance was associated with the eptA-like gene, which encodes a lipid A-modifying enzyme. SNP-based phylogenetic analysis revealed that the strain clustered with other strains isolated in Japan. The IMP-1/OXA-58-producing strain described in this study has a novel integron structure surrounding blaIMP-1, aacA and sul1.
Conclusions
Colistin-resistant IMP-1/OXA-58-co-producing A. colistiniresistens was identified in a patient. This isolate could serve as a reservoir for carbapenemase-producing organisms. This study suggests that screening for colistin-resistant isolates is crucial to preserve colistin as a therapeutic agent for multidrug-resistant bacteria. Identification of this MDR isolate in Asia, and the danger of it spreading worldwide, should raise serious concerns.
{"title":"Identification and characterisation of colistin-resistant Acinetobacter colistiniresistens co-producing IMP-1 and OXA-58 carbapenemases","authors":"Satoshi Nishida , Yasuo Ono","doi":"10.1016/j.nmni.2024.101484","DOIUrl":"10.1016/j.nmni.2024.101484","url":null,"abstract":"<div><h3>Background</h3><div>Carbapenem-resistant <em>Acinetobacter</em> is of increasing global concern because infections are challenging to treat with standard antibiotics. Here, we identified a previously uncharacterised <em>Acinetobacter</em> sp. clinical isolate as <em>Acinetobacter colistiniresistens</em> co-producing IMP-1 and OXA-58. We also examined expression of genes related to antibiotic susceptibility and drug resistance, including <em>bla</em><sub>IMP</sub>.</div></div><div><h3>Methods</h3><div>The isolate was deposited at the National Institute of Technology and Evaluation (NITE) as <em>Acinetobacter</em> sp. NBRC 110496. Susceptibility was defined according to the Clinical and Laboratory Standards Institute (CLSI) breakpoints. Genomic and clonal analyses were performed to identify species and resistance genes.</div></div><div><h3>Results</h3><div>The isolate was resistant to β-lactams, including broad-spectrum cephalosporins and carbapenems, polymyxins, and trimethoprim/sulfamethoxazole. Genomic analysis identified the isolate as <em>A. colistiniresistens</em> harbouring <em>bla</em><sub>IMP-1</sub>, <em>bla</em><sub>OXA-58</sub>, <em>bla</em><sub>OXA-670</sub>, <em>aac(6′)-Ib</em>, <em>aac(6′)-Ij</em>, <em>ant(3”)-I</em><em>I</em>, <em>aph(3’)-VI</em>, <em>msrE</em>, <em>mphE</em>, and <em>sul1</em>. Colistin resistance was associated with the <em>eptA</em>-like gene, which encodes a lipid A-modifying enzyme. SNP-based phylogenetic analysis revealed that the strain clustered with other strains isolated in Japan. The IMP-1/OXA-58-producing strain described in this study has a novel integron structure surrounding <em>bla</em><sub>IMP-1</sub>, <em>aacA</em> and <em>sul1</em>.</div></div><div><h3>Conclusions</h3><div>Colistin-resistant IMP-1/OXA-58-co-producing <em>A. colistiniresistens</em> was identified in a patient. This isolate could serve as a reservoir for carbapenemase-producing organisms. This study suggests that screening for colistin-resistant isolates is crucial to preserve colistin as a therapeutic agent for multidrug-resistant bacteria. Identification of this MDR isolate in Asia, and the danger of it spreading worldwide, should raise serious concerns.</div></div>","PeriodicalId":38074,"journal":{"name":"New Microbes and New Infections","volume":"62 ","pages":"Article 101484"},"PeriodicalIF":2.9,"publicationDate":"2024-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142318766","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-09-05DOI: 10.1016/j.nmni.2024.101483
Dalia Zayed, Mus'ab Banat, Ala'a B. Al-Tammemi
{"title":"Infectious diseases within a war-torn health system: The re-emergence of polio in Gaza","authors":"Dalia Zayed, Mus'ab Banat, Ala'a B. Al-Tammemi","doi":"10.1016/j.nmni.2024.101483","DOIUrl":"10.1016/j.nmni.2024.101483","url":null,"abstract":"","PeriodicalId":38074,"journal":{"name":"New Microbes and New Infections","volume":"62 ","pages":"Article 101483"},"PeriodicalIF":2.9,"publicationDate":"2024-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2052297524002671/pdfft?md5=5471af375968804b90d6d256b3ba9668&pid=1-s2.0-S2052297524002671-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142157607","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Naegleria Fowleri: The prevalence of a brain-eating amoeba in freshwater bodies in India","authors":"Vardhini Ganesh Iyer, Novonil Deb, Dattatreya Mukherjee, Sanjit Sah, Aroop Mohanty, Vikash Jaiswal , Ranjit Sah","doi":"10.1016/j.nmni.2024.101482","DOIUrl":"10.1016/j.nmni.2024.101482","url":null,"abstract":"","PeriodicalId":38074,"journal":{"name":"New Microbes and New Infections","volume":"62 ","pages":"Article 101482"},"PeriodicalIF":2.9,"publicationDate":"2024-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S205229752400266X/pdfft?md5=2596d0c84fdbca3e2e1d9bea607f000c&pid=1-s2.0-S205229752400266X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142157606","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Household animals and the risk of hepatitis E for pregnant women","authors":"Milad Zandi, Fatemeh Sadat Mousavi, Hashem Khanbabaei","doi":"10.1016/j.nmni.2024.101481","DOIUrl":"10.1016/j.nmni.2024.101481","url":null,"abstract":"","PeriodicalId":38074,"journal":{"name":"New Microbes and New Infections","volume":"62 ","pages":"Article 101481"},"PeriodicalIF":2.9,"publicationDate":"2024-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2052297524002658/pdfft?md5=c28d9c87b65c167ea07f70993a80cb9d&pid=1-s2.0-S2052297524002658-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142157450","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
扫码关注我们
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号